Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Synchrotron-based infrared microspectroscopy unveils the biomolecular response of healthy and tumour cell lines to neon minibeam radiation therapy

  • González-Vegas, Roberto|||0009-0000-4806-3092
  • Seksek, Olivier|||0000-0002-3053-3022
  • Bertho, Annaïg|||0009-0002-4526-0861
  • Bergs, J.
  • Hirayama, R.
  • Inaniwa, Taku
  • Matsufuji, N.
  • Shimokawa, Takashi|||0000-0001-6549-9277
  • Prezado, Yolanda|||0000-0001-5957-2327
  • Yousef, Ibraheem|||0000-0001-7818-8611
  • Martínez-Rovira, Immaculada|||0000-0002-2918-489X
Radioresistant tumours remain complex to manage with current radiotherapy (RT) techniques. Heavy ion beams were proposed for their treatment given their advantageous radiobiological properties. However, previous studies with patients resulted in serious adverse effects in the surrounding healthy tissues. Heavy ion RT could therefore benefit from the tissue-sparing effects of minibeam radiation therapy (MBRT). To investigate the potential of this combination, here we assessed the biochemical response to neon MBRT (NeMBRT) through synchrotron-based Fourier transform infrared microspectroscopy (SR-FTIRM). Healthy (BJ) and tumour (B16-F10) cell lines were subjected to seamless (broad beam) neon RT (NeBB) and NeMBRT at HIMAC. SR-FTIRM measurements were conducted at the MIRAS beamline of ALBA Synchrotron. Principal component analysis (PCA) permitted to assess the biochemical effects after the irradiations and 24 hours post-irradiation for the different RT modalities and doses. For the healthy cells, NeMBRT resulted in the most dissimilar spectral signatures from non-irradiated cells early after irradiations, mainly due to protein conformational modifications. Nevertheless, most of the damage appeared to recover one day post-RT; conversely, protein- and nucleic acid-related IR bands were strongly affected by NeBB 24 hours after treatment, suggesting superior oxidative damage and nucleic acid degradation. Tumour cells appeared to be less sensitive to NeBB than to NeMBRT shortly after RT. Still, after one day, both NeBB and the high-dose NeMBRT regions yielded important spectral modifications, suggestive of cell death processes, protein oxidation or oxidative stress. Lipid-associated spectral changes, especially due to the NeBB and NeMBRT peak groups for the tumour cell line, were consistent with reactive oxygen species attacks.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Investigating the biochemical response of proton minibeam radiation therapy by means of synchrotron-based infrared microspectroscopy

  • González-Vegas, Roberto|||0009-0000-4806-3092
  • Yousef, Ibraheem|||0000-0001-7818-8611
  • Seksek, Olivier|||0000-0002-3053-3022
  • Ortiz, Ramon
  • Bertho, Annaïg|||0009-0002-4526-0861
  • Juchaux, Marjorie
  • Nauraye, Catherine
  • Marzi, Ludovic De
  • Patriarca, Annalisa
  • Prezado, Yolanda|||0000-0001-5957-2327
  • Martínez-Rovira, Immaculada|||0000-0002-2918-489X
The biology underlying proton minibeam radiation therapy (pMBRT) is not fully understood. Here we aim to elucidate the biological effects of pMBRT using Fourier Transform Infrared Microspectroscopy (FTIRM). In vitro (CTX-TNA2 astrocytes and F98 glioma rat cell lines) and in vivo (healthy and F98-bearing Fischer rats) irradiations were conducted, with conventional proton radiotherapy and pMBRT. FTIRM measurements were performed at ALBA Synchrotron, and multivariate data analysis methods were employed to assess spectral differences between irradiation configurations and doses. For astrocytes, the spectral regions related to proteins and nucleic acids were highly affected by conventional irradiations and the high-dose regions of pMBRT, suggesting important modifications on these biomolecules. For glioma, pMBRT had a great effect on the nucleic acids and carbohydrates. In animals, conventional radiotherapy had a remarkable impact on the proteins and nucleic acids of healthy rats; analysis of tumour regions in glioma-bearing rats suggested major nucleic acid modifications due to pMBRT.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Synchrotron-based infrared microspectroscopy study on the biomolecular impact of carbon minibeam radiation therapy on a mouse osteosarcoma cell line

  • González-Vegas, Roberto|||0009-0000-4806-3092
  • Cots Costa, Martina|||0009-0005-2861-6899
  • Gilbert, Cristele
  • Bertho, Annaïg|||0009-0002-4526-0861
  • Seksek, Olivier|||0000-0002-3053-3022
  • Graeff, Christian|||0000-0002-5296-7649
  • Sokol, Olga|||0000-0003-3664-7538
  • Tinganelli, Walter|||0000-0003-0844-7272
  • Prezado, Yolanda|||0000-0001-5957-2327
  • Yousef, Ibraheem|||0000-0001-7818-8611
  • Martínez-Rovira, Immaculada|||0000-0002-2918-489X
Carbon minibeam radiation therapy (CMBRT) is a novel oncology treatment modality that combines the superior radiobiological properties of carbon ions with the remarkable tissue-sparing effects of spatial dose fractionation. Nevertheless, the differential biological mechanisms that CMBRT activates are not fully understood. To shed further light on such biomolecular processes, this study analysed the impact of CMBRT on LM8 osteosarcoma cells using synchrotron-based infrared microspectroscopy (SR-FTIRM). Samples were subjected to conventional carbon RT (CBB) and CMBRT at GSI (Germany). RT-treated cells underwent SR-FTIRM evaluations at ALBA Synchrotron (Spain) at 24 h post-RT. Principal component analysis (PCA) uncovered the main spectral differences between the treatment modalities, revealing that the IR signatures of CMBRT-treated samples were the most dissimilar from Control cells. Modifications of IR peaks attributed to α-helical and β-sheet protein sub-structures were consistent with the alterations of the Amide I spectral band due to CMBRT (assessed via curve-fitting analysis), suggesting enhanced protein oxidation. Conformational alterations in the sugar-phosphate backbone of nucleic acids might also have resulted from further oxidative damage due to CMBRT. Additionally, CMBRT led to greater alterations of methylene and methyl bands compared to CBB, which may have been caused by free radical attacks. Spectral signatures in the CMBRT valleys differed from those in the CMBRT peaks, suggesting distinct biomolecular mechanisms involved in these two dose regions. Comparison with proton and neon irradiations revealed common IR features affected by MBRT modalities.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Spatially modulated irradiation alters extracellular vesicle microRNA cargo in rat glioma and astrocyte models

  • Potiron, Sarah
  • Espenon, Julie
  • Gilbert, Cristele
  • Glayl, Ahmed
  • Fernández Rodríguez, Alfredo
  • Corvino, Angela
  • Juchaux, Marjorie
  • Prezado Alonso, Yolanda
Spatially fractionated radiation therapy, particularly minibeam radiation therapy (MBRT), improves normal tissue sparing while maintaining tumor control compared with conventional radiotherapy (CRT). However, the mechanisms underlying these advantages remain unclear. EVs carrying miRNAs are increasingly recognized as mediators of radiation-induced intercellular communication and may contribute to non-targeted and cohort effects. We investigated the impact of MBRT versus CRT on EV-miRNA profiles in glioma and normal astrocyte cell lines. Rat glioma (RG2, F98) and astrocyte (CTX-TNA2) cell lines were irradiated with X-ray CRT or MBRT. Small EVs were isolated 24 h post-irradiation, characterized by transmission electron microscopy and nanoflow cytometry, and analyzed by small RNA sequencing. EV morphology, size, and expression of canonical markers (CD9, CD63, CD81) were preserved across conditions, indicating that irradiation primarily altered EV cargo. Glioma cells showed limited and cell-dependent changes. In RG2 cells, CRT increased miR-6319 and miR-374-5p, whereas MBRT modulated miR-151-5p in a dose-dependent manner and reduced miR-466c-5p at 5 Gy. No significant changes were observed in F98 cells. In contrast, astrocytes exhibited marked remodeling of EV-miRNA cargo after irradiation, including enrichment of miRNAs associated with stress adaptation, hypoxia-related signalling, and immune regulation, together with consistent depletion of miR-122b and miR-486 across irradiation conditions. MBRT and CRT were associated with differential remodeling of EV miRNA cargo, with a markedly stronger response in astrocytes than in glioma cells. These findings suggest altered EV signaling potential following irradiation and provide an initial molecular framework for investigating how spatial dose modulation may influence extracellular communication. Further functional validation in human-relevant systems is required to determine mechanistic and translational significance
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A Potential Renewed Use of Very Heavy Ions for Therapy, Neon Minibeam Radiation Therapy

  • Prezado, Yolanda|||0000-0001-5957-2327
  • Hirayama, Ryochi
  • Matsufuji, Naruhiro
  • Inaniwa, Taku
  • Martínez-Rovira, Immaculada|||0000-0002-2918-489X
  • Seksek, Olivier|||0000-0002-3053-3022
  • Bertho, Annaïg|||0009-0002-4526-0861
  • Koike, Sachiko
  • Labiod, Dalila
  • Pouzoulet, Frederic
  • Polledo, Laura
  • Warfving, Nils
  • Liens, Aléthéa
  • Bergs, Judith|||0000-0003-2497-3248
  • Shimokawa, Takashi|||0000-0001-6549-9277
The treatment of hypoxic tumours continues to be one of the main challenges for radiation therapy. Minibeam radiation therapy (MBRT) shows a highly promising reduction of to-xicity in normal tissue, so that very heavy ions, such as Neon (Ne) or Argon (Ar), with extremely high LET, might become applicable to clinical situations. The high LET in the target would be unrivalled to overcome hypoxia, while MBRT might limit the side effects normally preventing the use of those heavy ions in a conventional radiotherapeutic setting. The work reported in this manuscript is the first experimental proof of the remarkable reduction of normal tissue (skin) toxicities after Ne MBRT irradiations as compared to conventional Ne irradiations. This result might allow for a renewed use of very heavy ions for cancer therapy. (1) Background: among all types of radiation, very heavy ions, such as Neon (Ne) or Argon (Ar), are the optimum candidates for hypoxic tumor treatments due to their reduced oxygen enhancement effect. However, their pioneering clinical use in the 1970s was halted due to severe side effects. The aim of this work was to provide a first proof that the combination of very heavy ions with minibeam radiation therapy leads to a minimization of toxicities and, thus, opening the door for a renewed use of heavy ions for therapy; (2) Methods: mouse legs were irradiated with either Ne MBRT or Ne broad beams at the same average dose. Skin toxicity was scored for a period of four weeks. Histopathology evaluations were carried out at the end of the study; (3) Results: a significant difference in toxicity was observed between the two irradiated groups. While severe da-mage, including necrosis, was observed in the broad beam group, only light to mild erythema was present in the MBRT group; (4) Conclusion: Ne MBRT is significantly better tolerated than conventional broad beam irradiations.